REGN

#254
Regeneron Pharmaceuticals, Inc. - Common Stock
618.2 3 USD
-0.53%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
616.19
618.23
Year Range
476.48
821.11
Daily Change
-0.53%
Monthly Change
-10.80%
6 month change
-20.32%
Year Change
+19.81%
Previous Close
621.5 2
Open
616.8 8
Low
616.1 9
High
618.2 3
Volume
427
Open full chart Full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
  • Market Capitalization 64.81 B
  • Employee 15 K
  • Founded 1988
  • CEO Leonard Schleifer
  • Website www.regeneron.com
  • Headquarter New York, United States
  • FIGI BBG000C734W3
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
18.86
Price to sales ratio
5.59
Dividends per share
0.94
Dividend yield %
0.46

Regeneron Pharmaceuticals, Inc. - Common Stock

Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap.

News